Risk of venous thromboembolism among women receiving ospemifene: a comparative observational study.

Beth L NordstromBin CaiFabio De GregorioLu BanKathy H FraemanYuki YoshidaTrevor Gibbs

Published in: Therapeutic advances in drug safety (2022)

This real-world safety analysis found no increase in risk of VTE or other adverse events with use of ospemifene in postmenopausal women.

Keyphrases